Differential inhibitory effects of protoberberines on sterol and chitin biosyntheses in Candida albicans.
The anti-Candida potentials of 12 Korean medicinal plants were explored: methanol extracts from Coptis rhizoma and Phellodendron amurense caused significant inhibition of growth of Candida albicans, Candida glabrata, Candida krusei and Candida parapsilosis. The predominant active components of the extracts were the protoberberines berberine and palmatine; the most potent inhibition of growth was exhibited by berberine on C. krusei (MIC <4 mg/L) and palmatine on C. parapsilosis (MIC 16 mg/L). Both berberine and palmatine inhibited the in-vivo rate of incorporation of L-[methyl-14C]methionine into C-24 of ergosterol in C. albicans (50% inhibition concentration (IC50 values), 25 microM and 300 microM, respectively); this result suggests that sterol 24-methyl transferase (24-SMT) is one of the cellular targets for the antifungal activity of the protoberberines. In-vitro 24-SMT activity in microsomes from the yeast growth form of C. albicans was inhibited by both berberine (inhibition constant (Ki) 232 microM) and palmatine (Ki 257 microM) in a non-competitive manner; inhibition of 24-SMT was more marked for the mycelial form than for the yeast growth form of this organism. Palmatine inhibited chitin synthase from both the yeast and mycelial growth phases of C. albicans in a non-competitive manner (Ki 780 microM). The effects of protoberberines, extracted from established medicinal plants, on both sterol and cell wall biosyntheses in pathogenic fungi indicate that the potential of these compounds, or their semi-synthetic derivatives, as a novel class of antifungal agents should be investigated more fully.
Park
K S
KS
Department of Biochemistry and Bioproducts Research Center, Yonsei University, Seoul, South Korea.
Kang
K C
KC
Kim
J H
JH
Adams
D J
DJ
Johng
T N
TN
Paik
Y K
YK
D000666:Amphotericin B / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology*; D001599:Berberine / Q000494:pharmacology*; D001600:Berberine Alkaloids / Q000494:pharmacology*; D002175:Candida / Q000187:drug effects / Q000378:metabolism*; D002176:Candida albicans / Q000187:drug effects / Q000378:metabolism*; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002473:Cell Wall / Q000187:drug effects / Q000378:metabolism; D002686:Chitin / Q000096:biosynthesis*; D002687:Chitin Synthase / Q000187:drug effects / Q000378:metabolism; D004875:Ergosterol / Q000096:biosynthesis; D008780:Methyltransferases / Q000187:drug effects / Q000378:metabolism; D008825:Miconazole / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D010936:Plant Extracts / Q000494:pharmacology*; D010946:Plants, Medicinal; D013261:Sterols / Q000096:biosynthesis*
D000935:Antifungal Agents; D001600:Berberine Alkaloids; D010936:Plant Extracts; D013261:Sterols; D001599:Berberine; D002686:Chitin; D008825:Miconazole; D000666:Amphotericin B; D008780:Methyltransferases; C022670:delta 24-sterol methyltransferase; D002687:Chitin Synthase; C005413:palmatine; D004875:Ergosterol